These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27637306)

  • 21. The evolution of anticoagulant therapy.
    Franchini M; Liumbruno GM; Bonfanti C; Lippi G
    Blood Transfus; 2016 Mar; 14(2):175-84. PubMed ID: 26710352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Acute Venous Thromboembolism.
    Nair S; Garza N; George M; Kaatz S
    Med Clin North Am; 2020 Jul; 104(4):631-646. PubMed ID: 32505257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. News in the Indications of Direct Oral Anticoagulants According to the American College of Chest Physicians 2016 Guidelines.
    Cesarman-Maus G; Ruiz-Argüelles GJ
    Curr Drug Metab; 2017; 18(7):651-656. PubMed ID: 28412908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New anticoagulants in the management of venous thromboembolism in women.
    Piovella F; Irina Iosub D
    Thromb Res; 2015 Feb; 135 Suppl 1():S5-7. PubMed ID: 25903537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New anticoagulants for the treatment of venous thromboembolism.
    Prandoni P; Dalla Valle F; Piovella C; Tormene D; Pesavento R
    Minerva Med; 2013 Apr; 104(2):131-39. PubMed ID: 23514989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the management of venous thromboembolism.
    Schulman S
    Best Pract Res Clin Haematol; 2012 Sep; 25(3):361-77. PubMed ID: 22959552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral anticoagulant monitoring: Are we on the right track?
    Onundarson PT; Flygenring B
    Int J Lab Hematol; 2019 May; 41 Suppl 1():40-48. PubMed ID: 31069986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venous thromboembolism: contemporary diagnostic and therapeutic aspects.
    Bounameaux H; Righini M; Perrier A
    Vasa; 2008 Aug; 37(3):211-26. PubMed ID: 18690588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Satisfaction, quality of life and therapy adherence assessment in real life patients transitioning from vitamin K antagonists to direct oral anticoagulants.
    Serrao A; Lucani B; Assanto Manfredi G; Fiori L; Baldacci E; Aprile SM; Chistolini A
    J Thromb Thrombolysis; 2020 Oct; 50(3):718-723. PubMed ID: 32112201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
    Hillis C; Crowther MA
    Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct Oral Anticoagulants and Their Use in Treatment and Secondary Prevention of Acute Symptomatic Venous Thromboembolism.
    Granziera S; Hasan A; Cohen AA
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):209-21. PubMed ID: 26329910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New oral anticoagulants versus vitamin K antagonists for treatment of acute venous thromboembolism: do they really increase the incidence of myocardial infarction?
    Liew A; Piran S; Douketis J
    Intern Emerg Med; 2015 Jun; 10(4):493-8. PubMed ID: 25820762
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vitamin K antagonist, direct oral anticoagulants: Where is the truth?].
    Laroche JP; Schved JF
    J Mal Vasc; 2016 Dec; 41(6):383-388. PubMed ID: 27817997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New anticoagulants in the treatment of venous thromboembolism].
    Bura-Rivière A
    Rev Prat; 2013 Sep; 63(7):980-4. PubMed ID: 24167902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are New Oral Anticoagulants Safer Than Vitamin K Antagonists in the Treatment of Venous Thromboembolism?
    Kolinsky DC; Schwarz ES
    Ann Emerg Med; 2016 Apr; 67(4):455-7. PubMed ID: 26440492
    [No Abstract]   [Full Text] [Related]  

  • 36. Direct oral anticoagulants in the treatment of pulmonary embolism.
    Eldredge JB; Spyropoulos AC
    Curr Med Res Opin; 2018 Jan; 34(1):131-140. PubMed ID: 28771049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of venous thromboembolism in patients with cancer: What news from clinical trials?
    Verso M; Franco L; Giustozzi M; Becattini C; Agnelli G
    Thromb Res; 2018 Apr; 164 Suppl 1():S168-S171. PubMed ID: 29703477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
    Brekelmans MP; Bleker SM; Bauersachs R; Boda Z; Büller HR; Choi Y; Gallus A; Grosso MA; Middeldorp S; Oh D; Raskob G; Schwocho L; Cohen AT
    Thromb Haemost; 2016 Jul; 116(1):155-61. PubMed ID: 27010092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New anticoagulants for the treatment of venous thromboembolism.
    Fernandes CJ; Alves Júnior JL; Gavilanes F; Prada LF; Morinaga LK; Souza R
    J Bras Pneumol; 2016 Apr; 42(2):146-54. PubMed ID: 27167437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venous thromboembolism management: where do novel anticoagulants fit?
    Spyropoulos AC; Turpie AG
    Curr Med Res Opin; 2013 Jul; 29(7):783-90. PubMed ID: 23659584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.